These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 9426339)
1. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen. Streit M; Jaehde U; Stremetzne S; Ridwelski K; Kerz H; Strohbach F; Hohenberger P; Zwiebel FM; Hebart H; Böthig R; Kairies M; Zillig D; Schuchmann S; Warnecke S; Thiel E; Kreuser ED Ann Oncol; 1997 Nov; 8(11):163-5. PubMed ID: 9426339 [TBL] [Abstract][Full Text] [Related]
2. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers. Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Klaassen U; Wilke H; Seeber S Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897 [TBL] [Abstract][Full Text] [Related]
4. Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study. Hartmann JT; Köhne CH; Schmoll HJ; Daikeler T; Kanz L; Bokemeyer C Oncology; 1998; 55(4):320-5. PubMed ID: 9663421 [TBL] [Abstract][Full Text] [Related]
5. Bolus/infusional 5-fluorouracil and folinic acid. A report on two prospective, consecutive phase II studies with 5-fluorouracil dose escalation. Mackean MJ; Cassidy J; Jodrell DI; Paul J; Reed NS; Canney PA; Yosef H; Habeshaw T; Robertson AG; McInnes A; Twelves CJ Br J Cancer; 1998 May; 77(9):1480-6. PubMed ID: 9652765 [TBL] [Abstract][Full Text] [Related]
6. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma. Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020 [TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology Group. Comella P; De Vita F; De Lucia L; Casaretti R; Avallone A; Orditura M; Rivellini F; Palmeri S; Catalano G; Comella G Ann Oncol; 2000 Apr; 11(4):461-8. PubMed ID: 10847467 [TBL] [Abstract][Full Text] [Related]
8. Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid. Wein A; Riedel C; Köckerling F; Martus P; Baum U; Brueckl WM; Reck T; Ott R; Hänsler J; Bernatik T; Becker D; Schneider T; Hohenberger W; Hahn EG Ann Oncol; 2001 Dec; 12(12):1721-7. PubMed ID: 11843250 [TBL] [Abstract][Full Text] [Related]
9. A phase II trial of weekly infusional 5-fluorouracil in combination with low-dose leucovorin in patients with advanced colorectal cancer. Haas NB; Schilder RJ; Nash S; Weiner LM; Catalano RC; Ozols RF; O'Dwyer PJ Invest New Drugs; 1995; 13(3):229-33. PubMed ID: 8729951 [TBL] [Abstract][Full Text] [Related]
10. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients. Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009 [TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954 [TBL] [Abstract][Full Text] [Related]
12. The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD). Aranda E; Cervantes A; Carrato A; Antón-Torres A; Massutí T; Fernández-Martos C; Díaz-Rubio E J Infus Chemother; 1996; 6(3):118-22. PubMed ID: 9229321 [TBL] [Abstract][Full Text] [Related]
13. Weekly oxaliplatin, high-dose folinic acid and 24h-5-fluorouracil (FUFOX) as salvage therapy in metastatic colorectal cancer patients pretreated with irinotecan and folinic acid/5-fluorouracil regimens. Moehler M; Hoffmann T; Hildner K; Siebler J; Galle PR; Heike M Z Gastroenterol; 2002 Dec; 40(12):957-64. PubMed ID: 12564419 [TBL] [Abstract][Full Text] [Related]
14. Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in patients with advanced colorectal cancer: Taiwan experience. Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Chen WS; Jiang JK; Yen CC; Fan FS; Hsieh RK Jpn J Clin Oncol; 1998 Jan; 28(1):16-9. PubMed ID: 9491136 [TBL] [Abstract][Full Text] [Related]
15. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial. Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806 [TBL] [Abstract][Full Text] [Related]
16. A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer. The Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD). Aranda E; Cervantes A; Dorta J; Blanco E; Fernández-Martos C; Cruz-Hernandez JJ; Carrato A; Gonzalez-Mancha R; García-Conde J; Díaz-Rubio E Cancer; 1995 Aug; 76(4):559-63. PubMed ID: 8625147 [TBL] [Abstract][Full Text] [Related]
17. Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial. Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD). Aranda E; Cervantes A; Carrato A; Fernández-Martos C; Antón-Torres A; Massutí T; Barneto I; García-Conde J; Barón JM; Díaz-Rubio E Ann Oncol; 1996 Aug; 7(6):581-5. PubMed ID: 8879371 [TBL] [Abstract][Full Text] [Related]
18. A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer. Garufi C; Lévi F; Aschelter AM; Pace R; Giunta S; Nisticò C; Gallà DA; Silecchia GF; Franchi F; Narduzzi C; Terzoli E Eur J Cancer; 1997 Sep; 33(10):1566-71. PubMed ID: 9389916 [TBL] [Abstract][Full Text] [Related]
19. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer. Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066 [TBL] [Abstract][Full Text] [Related]
20. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin. Klaassen U; Wilke H; Seeber S J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]